The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPIRI.L Regulatory News (PIRI)

  • There is currently no data for PIRI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ambisense launches new COVID-19 platform AmbiAir

2 Oct 2020 07:00

RNS Number : 8719A
Pires Investments PLC
02 October 2020
 

02 October 2020

 

Pires Investments plc

 

("Pires" or the "Company")

 

Ambisense launches new COVID-19 platform AmbiAir

 

Pires Investments plc (AIM: PIRI), the investment company focused on next generation technology, is pleased to provide an update on its investment in Sure Valley Ventures ("SVV") in relation to Ambisense, a company within the SVV portfolio, which provides sensors and an analysis platform to allow real-time gas and environmental monitoring.

 

Ambisense has announced its entry into the air quality market with the launch of AmbiAir, a solution designed to help manage, assess, and predict the COVID-19 risk in commercial and public buildings.

 

By increasing building ventilation, and combining it with measures such as social distancing, it is possible to decrease the COVID-19 risk in public spaces. Studies show that the danger of exposure to COVID-19 is reduced when the level of CO2 is below 600ppm, relative humidity is between 40-60%, and there are no or very minimal levels of PM2.5.

 

AmbiAir is a low-cost solution that combines discreet, multi-deployable hardware with Ambilytics, an intelligent platform that digs through the vast quantities of location-based data, to quickly and easily understand the performance of these critical risk drivers, identifying risk hot-spots in real-time, and predicting when safe levels are likely to be breached.

 

The first in a range of air quality solutions being released by Ambisense this year, AmbiAir combines multiple tools and techniques useful to air quality professionals to understand the behaviour of air quality pollutants.

 

Pires has a circa 13% interest in SVV. SVV is a venture capital fund focused on investing in the software technology sector with a specific focus on artificial intelligence, the internet of things and immersive technologies.

 

Peter Redmond, Chairman of Pires commented:

 

"Ambisense's launch of AmbiAir, a solution designed to help manage, assess, and predict the COVID-19 risk in commercial and public buildings, is particularly timely considering the challenges the global pandemic continues to bring to everyday living. AmbiAir is an innovative product to compliment already established measures safeguarding the public from COVID-19, aiming to reduce the risk of the virus in buildings and encourage employees to return to a safer working environment.

 

"Ambisense has vast experience in this industry and has proven its capabilities by launching this solution at a time when it is of significant demand. We look forward to updating the market with Ambisense's progress in due course."

 

- Ends -

 

Enquiries:

 

Pires Investments plc

Peter Redmond, Chairman

Nicholas Lee, Director

Tel: +44 (0) 20 3368 8961

 

Broker

Peterhouse Capital Limited

Duncan Vasey/Lucy Williams

 

Tel: +44 (0) 20 7469 0935

Tel: +44 (0) 20 7469 0936

Joint broker

Mirabaud Securities Limited

Peter Krens

 

Tel: +44 (0) 20 3167 7221

Financial media and PR

Yellow Jersey

Sarah Hollins

Henry Wilkinson

Annabel Atkins

 

Tel: +44 (0) 20 3004 9512

 

 

Notes to Editors

 

About Pires Investments plc

 

Pires Investments plc (AIM: PIRI) is an investment company providing investors with access to a portfolio of next generation technology businesses with significant growth potential.

 

The Company is building an investment portfolio of high-tech businesses across areas such as Artificial Intelligence ("AI"), Internet of Things ("IoT"), Cyber Security, Machine Learning, Immersive Technologies and Big Data, which the Board believes demonstrate evidence of traction and the potential for exponential growth, due to increasing global demand for development in these sectors.

 

For further information, visit: https://piresinvestments.com/.

 

About Ambisense

 

Since 2014, Ambisense has been driving innovation within the geo-environmental space. It accelerates and optimises the delivery of geo-environmental risk assessment on some of the world's largest infrastructure projects, and across industrial and waste verticals. Ambisense builds and deploys wireless solutions that, combined with its intelligent platform Ambilytics, gives users incredibly deep insights and improves their decision-making process.

 

Further information on Ambisense can be found at https://ambisense.net/. 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEFLFBBBLZFBL
Date   Source Headline
27th Jan 20217:00 amRNSExercise of Warrants
25th Jan 20217:00 amRNSNew SVV Investment in Virtex VR
21st Jan 20217:00 amRNSExercise of Warrants
19th Jan 20212:05 pmRNSSecond Price Monitoring Extn
19th Jan 20212:00 pmRNSPrice Monitoring Extension
19th Jan 20217:00 amRNSHolding(s) in Company
15th Jan 20217:00 amRNSCompletion of investment in decentralised finance
15th Jan 20217:00 amRNSExercise of Warrants
14th Jan 20212:10 pmRNSHolding(s) in Company
12th Jan 20212:00 pmRNSHolding(s) in Company
11th Jan 20217:00 amRNSCameraMatics raises EUR4m in Series A funding
8th Jan 20219:46 amRNSHolding(s) in Company
7th Jan 202112:16 pmRNSExercise of Warrant
7th Jan 202111:38 amRNSAppointment of Broker
4th Jan 202110:39 amRNSHolding(s) in Company
31st Dec 20207:00 amRNSHolding(s) in Company
31st Dec 20207:00 amRNSHolding(s) in Company
29th Dec 20209:47 amRNSHolding(s) in Company
14th Dec 20207:00 amRNSInvestment in Low6
2nd Dec 202011:31 amRNSInvestment in decentralised finance
21st Oct 20207:00 amRNSChange of accounting reference date
6th Oct 202012:40 pmRNSVRE Update
6th Oct 20207:00 amRNSBuymie partners with Dunnes Stores
2nd Oct 20207:00 amRNSAmbisense launches new COVID-19 platform AmbiAir
1st Oct 20208:30 amRNSHolding(s) in Company
29th Sep 20207:00 amRNSAdmix fundraise
21st Sep 20201:00 pmRNSHolding(s) in Company
17th Sep 20207:00 amRNSVividQ Update
16th Sep 20207:00 amRNSExercise of Warrant
4th Sep 202012:26 pmRNSHolding(s) in Company
2nd Sep 20204:54 pmRNSHolding(s) in Company
1st Sep 20207:00 amRNSExercise of Warrant
28th Aug 20209:57 amRNSHolding(s) in Company
17th Aug 20209:15 amRNSHolding(s) in Company
12th Aug 202010:40 amRNSHolding(s) in Company
11th Aug 20207:00 amRNSGetvisibility signs distribution agreement
31st Jul 20207:00 amRNSHalf-year Report
29th Jul 202012:19 pmRNSHolding(s) in Company
29th Jul 20207:00 amRNSNew SVV investment in Volograms Limited
20th Jul 20209:10 amRNSHolding(s) in Company
10th Jul 20207:00 amRNSAppointment of Joint Broker
3rd Jul 202012:09 pmRNSHolding(s) in Company
1st Jul 20202:36 pmRNSUpdate re portfolio companies
30th Jun 20204:11 pmRNSTotal Voting Rights
26th Jun 20207:02 amRNSGetvisibility video interview
25th Jun 20207:00 amRNSInvestor Presentation
24th Jun 20201:30 pmRNSResult of AGM
22nd Jun 20207:02 amRNSBroadcast Interview with Share Talk
22nd Jun 20207:00 amRNSPartial sale of shareholding in VR Education
15th Jun 20207:00 amRNSBuymie fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.